Latest debt-to-equity ratio

Royalty Pharma Debt-to-equity ratio

Direct answer

Royalty Pharma's debt-to-equity ratio is 87.67%.

The verified market snapshot reports 87.67%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked November 19, 2026.

Get free Royalty Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
87.67%